Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Collagen Peptides Market Worth $795 Million by 2025 - Exclusive Report by MarketsandMarkets™

This image opens in the lightbox

News provided by

MarketsandMarkets

02 Jun, 2020, 11:30 GMT

Share this article

Share toX

Share this article

Share toX

CHICAGO, June 2, 2020 /PRNewswire/ -- According to MarketsandMarkets™, the "Collagen Peptides Market by Source (Bovine, Porcine, and Marine & Poultry), Form (Dry and Liquid), Application (Nutritional Products, Food & Beverages, Pharmaceuticals, and Cosmetics & Personal Care Products) and Region - Global Forecast to 2025", published by MarketsandMarkets™, the Collagen Peptides Market is estimated to be valued at USD 599 million in 2020 and projected to reach USD 795 million by 2025, recording a CAGR of 5.8%. Due to the growing awareness among consumers regarding a healthy lifestyle and with technological advancement, collagen peptides are being used increasingly in the pharmaceutical industry. These factors have been contributing to the growth of the collagen peptides industry.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=248590980

The pharmaceutical segment, across various applications, is projected to witness significant growth during the forecast period.

Research advances and biotechnological advancement has discovered the utilization and incorporation of collagen peptides in pharmaceutical applications and biomedical uses. Collagen peptides are used in medical devices, scaffolds for tissue regeneration, and in the drug delivery system. Manufacturers specially design them to meet the stringent safety and quality specifications for emerging biomedical applications.

Browse in-depth TOC on "Collagen Peptides Market"
121 – Tables
49 – Figures  
168 – Pages

The bovine segment is projected to account for a major share in the collagen peptides market during the forecast period

Based on source, the market is segmented into bovine, porcine, and marine & poultry. The bovine segment is estimated to account for the largest share of the collagen peptides market, as it is a primary source due to its easy availability and biocompatibility. Also, bovine-sourced collagen peptides contain Type I and Type III collagen, which are essential constituents of human skin. The key benefits associated with collagen peptides extracted from bovine sources are that they hydrate the skin, support muscle strength, heal the gut, and support hair growth.

Speak to Analyst:
https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=248590980

Europe dominated the global collagen peptides market, with the largest share in 2019, whereas Asia Pacific is projected to witness the highest growth rate.

Europe has the largest share in the global market because collagen peptides are used across a wide range of applications in that region. Technological advancements have led to the identification of more uses of collagen peptides in pharmaceutical and biomedical applications. It is used as a constituent of wound dressing, blood volume substitutes, and hemostatic sponges. Also, manufacturers use collagen peptides in dietary supplements and orally administer medicines owing to their unique adhesive, gelling, and film-building properties. Whereas, the Asia Pacific collagen peptides market is projected to grow at the highest rate. The rising demand for functional ingredients in food & beverage products and consumers becoming more aware of their health and wellness are driving the growth of the collagen peptides industry in this region. Collagen peptides infused food & beverage products have longer shelf lives.

This report includes a study on the marketing and development strategies, along with the product portfolios of leading companies. It consists of profiles of leading companies, such as Tessenderlo Group (Belgium), Gelita AG (Germany), Holista CollTech (Australia), Darling Ingredients (Texas), Nitta Gelatin (Japan), Weishardt (France), Gelnex (Brazil), Collagen Solutions (UK), Amicogen Inc. (South Korea), and Nippi Inc. (Japan), Lapi Gelatine (Italy), Ewald-Gelatine (Germany), Crescent Biotech (India), Foodmate Co. Ltd. (China), Suboneyo Chemicals Pharmaceuticals Pvt. Ltd. (India), BioCell Technology (US), Kayos (India), Aspen Naturals (US), Vital Proteins (US), and Chaitanya Chemicals (India).

Related Reports:

Collagen Market by Product Type (Gelatin, Hydrolyzed Collagen, and Native Collagen), Source, Application (Food & Beverages, Pharmaceutical & Healthcare), and Region (North America, Europe, Asia Pacific, and Row) - Global Forecast to 2023
https://www.marketsandmarkets.com/Market-Reports/collagen-market-220005202.html

Gelatin Market by Source (Porcine, Bovine Skin, Bovine Bone, Fish & Poultry), Application (Food, Pharmaceuticals & Healthcare), Type (Type A, Type B), Function (Stabilizing, Thickening, Gelling), and Region - Global Forecast to 2023
https://www.marketsandmarkets.com/Market-Reports/gelatin-market-850.html

Browse Adjacent Markets: F & B Ingredients Market Research Reports & Consulting

About MarketsandMarkets™ 

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062~
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com 
Visit Our Web Site: https://www.marketsandmarkets.com 
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/collagen-peptide-market.asp 
Content Source: https://www.marketsandmarkets.com/PressReleases/collagen-peptide.asp

Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg  

Modal title

Also from this source

MarketsandMarkets' 360Quadrants Recognizes Top Startups and SMEs in the PFAS Testing Quadrant Report 2025

MarketsandMarkets' 360Quadrants Recognizes Top Startups and SMEs in the PFAS Testing Quadrant Report 2025

360Quadrants has released its latest PFAS testing Startups/SMEs Companies Assessment, 2025, recognizing key players, including both global giants and ...

Healthcare Simulation Market worth US$7.23 billion by 2030 with 15.6% CAGR | MarketsandMarkets™

Healthcare Simulation Market worth US$7.23 billion by 2030 with 15.6% CAGR | MarketsandMarkets™

The global Healthcare Simulation Market, valued at US$3.00 billion in 2024 stood at US$3.50 billion in 2025 and is projected to advance at a...

More Releases From This Source

Explore

Food & Beverages

Food & Beverages

Beverages

Beverages

Medical Pharmaceuticals

Medical Pharmaceuticals

Health Care & Hospitals

Health Care & Hospitals

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.